在胃肠道癌患者中检测到的 基因和 基因的错义突变与外显子剪接增强子和沉默子相关。

Missense mutations of and genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers.

作者信息

Zhu Ming, Chen Hui-Mei, Wang Ya-Ping

机构信息

Jiangsu Key Laboratory of Molecular Medicine, Nanjing University School of Medicine, Nanjing 210093; ; Department of Molecular Biology, Jiangsu Institute of Cancer Research, Nanjing 210009, P.R. China.

出版信息

Oncol Lett. 2013 May;5(5):1710-1718. doi: 10.3892/ol.2013.1243. Epub 2013 Mar 11.

Abstract

The and genes in DNA mismatch repair are important in the pathogenesis of gastrointestinal cancer. Recent studies of normal and alternative splicing suggest that the deleterious effects of missense mutations may in fact be splicing-related when they are located in exonic splicing enhancers (ESEs) or exonic splicing silencers (ESSs). In this study, we used ESE-finder and FAS-ESS software to analyze the potential ESE/ESS motifs of the 114 missense mutations detected in the two genes in East Asian gastrointestinal cancer patients. In addition, we used the SIFT tool to functionally analyze these mutations. The amount of the ESE losses (68) was 51.1% higher than the ESE gains (45) of all the mutations. However, the amount of the ESS gains (27) was 107.7% higher than the ESS losses (13). In total, 56 (49.1%) mutations possessed a potential exonic splicing regulator (ESR) error. Eighty-one mutations (71.1%) were predicted to be deleterious with a lower tolerance index as detected by the Sorting Intolerant from Tolerant (SIFT) tool. Among these, 38 (33.3%) mutations were predicted to be functionally deleterious and possess one potential ESR error, while 18 (15.8%) mutations were predicted to be functionally deleterious and exhibit two potential ESR errors. These may be more likely to affect exon splicing. Our results indicated that there is a strong correlation between missense mutations in and genes detected in East Asian gastrointestinal cancer patients and ESR motifs. In order to correctly understand the molecular nature of mutations, splicing patterns should be compared between wild-type and mutant samples.

摘要

DNA错配修复中的 和 基因在胃肠道癌的发病机制中很重要。最近对正常剪接和可变剪接的研究表明,错义突变的有害影响实际上可能与剪接相关,当它们位于外显子剪接增强子(ESEs)或外显子剪接沉默子(ESSs)中时。在本研究中,我们使用ESE-finder和FAS-ESS软件分析了东亚胃肠道癌患者这两个基因中检测到的114个错义突变的潜在ESE/ESS基序。此外,我们使用SIFT工具对这些突变进行功能分析。所有突变中ESE丢失的数量(68个)比ESE获得的数量(45个)高51.1%。然而,ESS获得的数量(27个)比ESS丢失的数量(13个)高107.7%。总共有56个(49.1%)突变存在潜在的外显子剪接调节因子(ESR)错误。通过排序不耐受与耐受(SIFT)工具检测,81个突变(71.1%)被预测为有害,耐受指数较低。其中,38个(33.3%)突变被预测为功能有害且存在一个潜在的ESR错误,而18个(15.8%)突变被预测为功能有害且存在两个潜在的ESR错误。这些可能更有可能影响外显子剪接。我们的结果表明,东亚胃肠道癌患者中检测到的 和 基因错义突变与ESR基序之间存在很强的相关性。为了正确理解突变的分子性质,应该比较野生型和突变样本之间的剪接模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e502/3678577/2acbc64e6a54/OL-05-05-1710-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索